Home / Resource Library / Checkpoint Inhibition Therapy in Transplant Ineligible Relapsed or Refractory Classic Hodgkin LymphomaCheckpoint Inhibition Therapy in Transplant Ineligible Relapsed or Refractory Classic Hodgkin Lymphoma